Market revenue in 2024 | USD 63.3 million |
Market revenue in 2030 | USD 99.1 million |
Growth rate | 7.8% (CAGR from 2025 to 2030) |
Largest segment | Diphtheria toxin (dt) |
Fastest growing segment | Diphtheria Toxin (DT) |
Historical data covered | 2018 - 2023 |
Base year for estimation | 2024 |
Forecast period covered | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Diphtheria Toxin (DT), Anthrax Based Toxins, Pseudomonas Exotoxin (PE), Other Immunotoxins |
Key market players worldwide | Creative-Biolabs, The Native Antigen Company, Bio-Techne Corp, Abcam PLC, Cayman Chemical, Merck KGaA, Enzo Biochem Inc, Santa Cruz Biotechnology (SCBT) |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to immunotoxins market will help companies and investors design strategic landscapes.
Diphtheria toxin (dt) was the largest segment with a revenue share of 42.65% in 2024. Horizon Databook has segmented the North America immunotoxins market based on diphtheria toxin (dt), anthrax based toxins, pseudomonas exotoxin (pe), other immunotoxins covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America immunotoxins market , including forecasts for subscribers. This continent databook contains high-level insights into North America immunotoxins market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account